275 related articles for article (PubMed ID: 22991940)
1. Label-free mapping of osteopontin adsorption to calcium oxalate monohydrate crystals by tip-enhanced Raman spectroscopy.
Kazemi-Zanjani N; Chen H; Goldberg HA; Hunter GK; Grohe B; Lagugné-Labarthet F
J Am Chem Soc; 2012 Oct; 134(41):17076-82. PubMed ID: 22991940
[TBL] [Abstract][Full Text] [Related]
2. Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide.
Grohe B; O'Young J; Ionescu DA; Lajoie G; Rogers KA; Karttunen M; Goldberg HA; Hunter GK
J Am Chem Soc; 2007 Dec; 129(48):14946-51. PubMed ID: 17994739
[TBL] [Abstract][Full Text] [Related]
3. Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.
Taller A; Grohe B; Rogers KA; Goldberg HA; Hunter GK
Biophys J; 2007 Sep; 93(5):1768-77. PubMed ID: 17496021
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals.
O'Young J; Chirico S; Al Tarhuni N; Grohe B; Karttunen M; Goldberg HA; Hunter GK
Cells Tissues Organs; 2009; 189(1-4):51-5. PubMed ID: 18728346
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.
Gleberzon JS; Liao Y; Mittler S; Goldberg HA; Grohe B
Urolithiasis; 2019 Oct; 47(5):425-440. PubMed ID: 30569197
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy.
Langdon A; Wignall GR; Rogers K; Sørensen ES; Denstedt J; Grohe B; Goldberg HA; Hunter GK
Calcif Tissue Int; 2009 Mar; 84(3):240-8. PubMed ID: 19189038
[TBL] [Abstract][Full Text] [Related]
7. Reversible inhibition of calcium oxalate monohydrate growth by an osteopontin phosphopeptide.
Nene SS; Hunter GK; Goldberg HA; Hutter JL
Langmuir; 2013 May; 29(21):6287-95. PubMed ID: 23611580
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin.
Hunter GK; Grohe B; Jeffrey S; O'Young J; Sørensen ES; Goldberg HA
Cells Tissues Organs; 2009; 189(1-4):44-50. PubMed ID: 18703867
[TBL] [Abstract][Full Text] [Related]
9. Molecular modulation of calcium oxalate crystallization.
De Yoreo JJ; Qiu SR; Hoyer JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
[TBL] [Abstract][Full Text] [Related]
10. Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions.
Grohe B; Taller A; Vincent PL; Tieu LD; Rogers KA; Heiss A; Sørensen ES; Mittler S; Goldberg HA; Hunter GK
Langmuir; 2009 Oct; 25(19):11635-46. PubMed ID: 19725562
[TBL] [Abstract][Full Text] [Related]
11. Citrate modulates calcium oxalate crystal growth by face-specific interactions.
Grohe B; O'Young J; Langdon A; Karttunen M; Goldberg HA; Hunter GK
Cells Tissues Organs; 2011; 194(2-4):176-81. PubMed ID: 21555861
[TBL] [Abstract][Full Text] [Related]
12. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
13. On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.
Chan BP; Vincent K; Lajoie GA; Goldberg HA; Grohe B; Hunter GK
Colloids Surf B Biointerfaces; 2012 Aug; 96():22-8. PubMed ID: 22503630
[TBL] [Abstract][Full Text] [Related]
14. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
Langdon A; Grohe B
Colloids Surf B Biointerfaces; 2016 Oct; 146():296-306. PubMed ID: 27362921
[TBL] [Abstract][Full Text] [Related]
15. Attachment of calcium oxalate monohydrate crystals on patterned surfaces of proteins and lipid bilayers.
An Z; Lee S; Oppenheimer H; Wesson JA; Ward MD
J Am Chem Soc; 2010 Sep; 132(38):13188-90. PubMed ID: 20812679
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hyaluronic acid interaction with calcium oxalate crystals: implication of crystals faces, pH and citrate.
Lamontagne CA; Plante GE; Grandbois M
J Mol Recognit; 2011; 24(4):733-40. PubMed ID: 21584883
[TBL] [Abstract][Full Text] [Related]
17. Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.
Thurgood LA; Cook AF; Sørensen ES; Ryall RL
Urol Res; 2010 Oct; 38(5):357-76. PubMed ID: 20652561
[TBL] [Abstract][Full Text] [Related]
18. Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney.
Okada A; Nomura S; Saeki Y; Higashibata Y; Hamamoto S; Hirose M; Itoh Y; Yasui T; Tozawa K; Kohri K
J Bone Miner Res; 2008 Oct; 23(10):1629-37. PubMed ID: 18505365
[TBL] [Abstract][Full Text] [Related]
19. Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.
Chien YC; Masica DL; Gray JJ; Nguyen S; Vali H; McKee MD
J Biol Chem; 2009 Aug; 284(35):23491-501. PubMed ID: 19581305
[TBL] [Abstract][Full Text] [Related]
20. Exploring calcium oxalate crystallization: a constant composition approach.
Kolbach-Mandel AM; Kleinman JG; Wesson JA
Urolithiasis; 2015 Oct; 43(5):397-409. PubMed ID: 26016572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
